Use of cilomilast-loaded phosphatiosomes to suppress neutrophilic inflammation for attenuating acute lung injury: the effect of nanovesicular surface charge

BACKGROUND: Cilomilast is a phosphodiesterase 4 (PDE4) inhibitor for treating inflammatory lung diseases. This agent has a narrow therapeutic index with significant adverse effects on the nervous system. This study was conducted to entrap cilomilast into PEGylated phosphatidylcholine-rich niosomes (...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Fu-Chao, Yu, Huang-Ping, Lin, Cheng-Yu, Elzoghby, Ahmed O., Hwang, Tsong-Long, Fang, Jia-You
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877390/
https://www.ncbi.nlm.nih.gov/pubmed/29602314
http://dx.doi.org/10.1186/s12951-018-0364-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5877390/
https://www.ncbi.nlm.nih.gov/pubmed/29602314
http://dx.doi.org/10.1186/s12951-018-0364-z

Ejemplares similares